Skip to content

Application of different doses of remimazolam combined with alfentanil in painless gastroscopy for children

Application of different doses of remimazolam combined with alfentanil in painless gastroscopy for children

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076282
Enrollment
Unknown
Registered
2023-09-28
Start date
2023-10-02
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless gastroscope anesthesia

Interventions

Group C:Intravenous injection of alfentanil was 7 µ g/kg, and intravenous injection of propofol was 2 mg/kg in group C. When the patient s MOAA/S score is =1, the patient will start to enter the gastr
Group R1:Intravenous injection of alfentanil was 7 µ g/kg, and intravenous injection of remimazolam was 0.2 mg/kg in R1 group. When the patient s MOAA/S score is =1, the patient will start to enter th
Group R2:Intravenous injection of alfentanil was 7 µ g/kg, and intravenous injection of remimazolam was 0.3 mg/kg in R2group. When the patient s MOAA/S score is =1, the patient will start to enter the
Group R3:Intravenous injection of alfentanil was 7 µ g/kg, and intravenous injection of remimazolam was 0.4 mg/kg in R3 group. When the patient s MOAA/S score is =1, the patient will start to enter th

Sponsors

Gansu Provincial Maternity and Child-care Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 12 Years

Inclusion criteria

Inclusion criteria: (1)Simple gastroscopy was performed with total intravenous anesthesia; (2) 3-12 years old; (3) ASA classification I ~ II; (4) can tolerate anesthesia and gastroscopy; (5) Sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) those who need tracheal intubation for general anesthesia; (2) ASA grade is greater than Grade II; (3) those who are allergic to research drug; (4) patients and their families refused.

Design outcomes

Primary

MeasureTime frame
Number of successful cases of sedation;Sedation onset time;Awakening event;

Secondary

MeasureTime frame
blood pressure;heart rate;Operation time;Anesthesia time;Surgeon satisfactio;Oxygen saturation;Body movement;

Countries

China

Contacts

Public ContactLiu Huifang

Gansu Provincial Maternity and Child-care Hospital

344079827@qq.com+86 151 0128 3250

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026